Biggest study yet backs Glaxo cervical cancer shot

Source: Reuters

GlaxoSmithKline Plc's experimental vaccine Cervarix has proved more than 90 percent effective in preventing precancerous lesions due to two types of a virus responsible for most cases of cervical cancer.

External Link:

News, Press & Media Mentions

  • Algodon Mansion
  • Algodon Wine & Wellness Resort
  • Algodon Fine Wines
  • Algodon Group